U.S. Markets close in 5 hrs 25 mins
  • S&P 500

    4,209.43
    +42.98 (+1.03%)
     
  • Dow 30

    33,775.22
    +485.14 (+1.46%)
     
  • Nasdaq

    14,074.03
    +43.66 (+0.31%)
     
  • Russell 2000

    2,266.60
    +28.86 (+1.29%)
     
  • Crude Oil

    72.93
    +1.29 (+1.80%)
     
  • Gold

    1,777.40
    +8.40 (+0.47%)
     
  • Silver

    25.94
    -0.03 (-0.11%)
     
  • EUR/USD

    1.1918
    +0.0052 (+0.4410%)
     
  • 10-Yr Bond

    1.4820
    +0.0320 (+2.21%)
     
  • Vix

    19.04
    -1.66 (-8.02%)
     
  • GBP/USD

    1.3909
    +0.0100 (+0.7247%)
     
  • USD/JPY

    110.1950
    +0.0450 (+0.0409%)
     
  • BTC-USD

    32,711.94
    -1,499.00 (-4.38%)
     
  • CMC Crypto 200

    800.82
    -49.52 (-5.82%)
     
  • FTSE 100

    7,042.91
    +25.44 (+0.36%)
     
  • Nikkei 225

    28,010.93
    -953.15 (-3.29%)
     

Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

MONTREAL, May 18, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will participate in a virtual fireside chat hosted by Edward Nash at Canaccord Genuity on Thursday, May 20, 2021 at 2:00 p.m. ET.

The live webcast will be available at https://www.webcaster4.com/Webcast/Page/2332/40747. The live and archived webcast link will also be available in the ‘News’ section of the Company’s website.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.


For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800

For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
ir@theratech.com
617-356-1009